Impact of Genetic Polymorphisms on Treatment Outcomes of Proteasome Inhibitors and Immunomodulatory Drugs in Multiple Myeloma
Fatemeh Karimi, Mojtaba Aghaei, Najmaldin Saki
Topics & Concepts
MedicinePharmacogeneticsMultiple myelomaMalignancyDrugHematologic malignancyOncologyBioinformaticsPharmacogenomicsCarfilzomibProteasome inhibitorInternal medicinePharmacologyGeneGenotypeGeneticsBiologyMultiple Myeloma Research and TreatmentsProtein Degradation and InhibitorsPeptidase Inhibition and Analysis